Argyle Capital Partners
AMGN icon

Argyle Capital Partners’s Amgen AMGN Stock Holding History

Argyle Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.01M Sell
4,776
-75
-2% -$29.9K 1.25% 20
2026
Q2 		$1.76M Buy
4,851
+254
+6% +$86.9K 1.11% 25
2026
Q1 		$1.62M Sell
4,597
-299
-6% -$107K 1.16% 24
2025
Q4 		$1.6M Sell
4,896
-667
-12% -$212K 1.17% 22
2025
Q3 		$1.57M Buy
5,563
+509
+10% +$148K 1.13% 24
2025
Q2 		$1.41M Sell
5,054
-126
-2% -$35.7K 1.16% 23
2025
Q1 		$1.61M Sell
5,180
-141
-3% -$41.6K 1.38% 18
2024
Q4 		$1.39M Buy
+5,321
New +$1.58M 1.19% 23

Other funds holding AMGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Smead Capital Management
Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Forum Financial Management
Forum Financial Management Lombard, Illinois $7.7B AUM 11.59% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sumitomo Mitsui DS Asset Management
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.8B AUM 30.39% 1-Year Est. Return
OpenArc Corporate Advisory
OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Argyle Capital Partners's AMGN Position: Q3 2026 in Review

Argyle Capital Partners reduced its Amgen (AMGN) stake by 1.5% in Q3 2026, selling an estimated $29.9K and leaving 4,776 shares worth $2.01M. The position accounts for 1.25% of the portfolio, ranked #20.

Argyle Capital Partners first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 1,149 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Argyle Capital Partners held 4,776 shares of Amgen worth $2.01M as of Q3 2026.
  • Argyle Capital Partners sold 75 Amgen shares in Q3 2026, an estimated $29.9K.
  • Amgen made up 1.25% of Argyle Capital Partners's portfolio in Q3 2026, its #20 holding.
  • Argyle Capital Partners first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 1,149 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Argyle Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.